Lammi Matthew R, Saketkoo Lesley Ann, Gordon Jessica K, Steen Virginia D
1 Lousiana State University Health Sciences Center, New Orleans, LA, USA.
2 12255 Comprehensive Pulmonary Hypertension Center-University Medical Center New Orleans, New Orleans, LA, USA.
Pulm Circ. 2018 Apr-Jun;8(2):2045893218757404. doi: 10.1177/2045893218757404.
Group classification of pulmonary hypertension (PH) is based on pulmonary artery wedge pressure (PAWP) on right heart catheterization (RHC). How hemodynamics, particularly PAWP, change over time in systemic sclerosis (SSc)-PH patients is unknown. SSc-PH patients enrolled in the prospective observational PHAROS registry who had > 1 RHC (n = 120) were included in this analysis. Patients were considered to have a "PAWP class change" if they had a PAWP ≤ 15 mmHg on RHC-1 and then a PAWP > 15 on RHC-2 or had a PAWP > 15 on RHC-1 and then PAWP ≤ 15 on RHC-2. There was a median time of 1.4 years between RHC-1 and RHC-2 and 75% of patients had a PH medication added after their initial RHC. PAWP increased significantly (11 ± 5 versus 13 ± 6 mmHg, P = 0.01) between RHC-1 and RHC-2, particularly for patients who were started on PH medications. Overall, 30% of patients who had a repeat RHC experienced a PAWP class change between their initial and follow-up RHC, independent of whether a PH medication was added. Patients initially classified as World Health Organization group 2 PH were most likely to change PAWP class over time. In conclusion, PAWP values commonly change to a significant degree in SSc-PH, which highlights the challenges in using a single time-point PAWP to define clinical classification groups.
肺动脉高压(PH)的分组是基于右心导管检查(RHC)时的肺动脉楔压(PAWP)。目前尚不清楚在系统性硬化症(SSc)相关性PH患者中,血流动力学,尤其是PAWP,随时间如何变化。本分析纳入了前瞻性观察性PHAROS注册研究中接受过1次以上RHC检查的SSc-PH患者(n = 120)。如果患者在RHC-1时PAWP≤15 mmHg,而在RHC-2时PAWP>15 mmHg,或者在RHC-1时PAWP>15 mmHg,而在RHC-2时PAWP≤15 mmHg,则认为患者发生了“PAWP类别改变”。RHC-1和RHC-2之间的中位时间为1.4年,75%的患者在首次RHC检查后添加了PH药物。RHC-1和RHC-2之间PAWP显著升高(11±5与13±6 mmHg,P = 0.01),尤其是开始使用PH药物的患者。总体而言,30%接受重复RHC检查的患者在初始和随访RHC之间经历了PAWP类别改变,这与是否添加PH药物无关。最初被归类为世界卫生组织第2组PH的患者随着时间推移最有可能改变PAWP类别。总之,在SSc-PH中,PAWP值通常会发生显著变化,这凸显了使用单个时间点的PAWP来定义临床分类组所面临的挑战。